Introduction: Gastric cancer is among the most common cancers worldwide. Despite
declining incidences, the prognosis remains dismal in Western countries and is better in …

Gastric cancer is one of the most common malignancies worldwide. During the last 50 years,
the histological classification of gastric carcinoma has been largely based on Lauren's …

Gastric cancer is one of the most common cancers and one of the most frequent causes of
cancer-related deaths. The incidence, diagnostic studies, and therapeutic options have …

Purpose: We evaluated the association between molecular subtypes of advanced gastric
cancer (AGC) and the efficacy of standard chemotherapy or immune checkpoint inhibitors …

Progress in gastric cancer has been slow, but steady. Historically, patients commonly
presented with significant disease related co-morbidity and received treatment of marginal …

Simple Summary Advanced gastric cancer remains a malignancy with a poor prognosis,
with a median survival of about 12–15 months. In recent years, immune checkpoint inhibitors …

As one of the most common forms of solid tumours, gastric carcinoma has been revealed as
the third leading cause of death worldwide. The symptom of gastric cancer is usually not …

Gastric cancer is the second most frequent cancer in the world. Approximately 84% of
patients with gastric cancer will have advanced disease and median survival of these …

The recent successes being achieved with combination chemotherapy regimens, such as
FAMTX (fluorouracil [5-FU], doxorubicin, methotrexate), EAP (etoposide, doxorubicin …

Gastric cancer is one of the most common cancers and one of the most frequent causes of
cancer-related deaths. The incidence, diagnostic studies, and therapeutic options have …